These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16008507)

  • 1. The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong?
    Singh JA; Mills EJ
    PLoS Med; 2005 Sep; 2(9):e234. PubMed ID: 16008507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. We must not let protestors derail trials of pre-exposure prophylaxis for HIV.
    Lange JM
    PLoS Med; 2005 Sep; 2(9):e248. PubMed ID: 16008501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The trials of tenofovir trials.
    Lancet; 2005 Mar 26-Apr 1; 365(9465):1111. PubMed ID: 15799093
    [No Abstract]   [Full Text] [Related]  

  • 4. Unethical clinical trials in Thailand: a community response.
    Jintarkanon S; Nakapiew S; Tienudom N; Suwannawong P; Wilson D
    Lancet; 2005 May 7-13; 365(9471):1617-8. PubMed ID: 15885287
    [No Abstract]   [Full Text] [Related]  

  • 5. Unethical clinical trials in Thailand: a community response.
    Loff B; Jenkins C; Ditmore M; Overs C; Barbero R
    Lancet; 2005 May 7-13; 365(9471):1618-9. PubMed ID: 15889464
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral tenofovir arm of VOICE trial discontinued early.
    McEnery R
    IAVI Rep; 2011; 15(5):21. PubMed ID: 22121550
    [No Abstract]   [Full Text] [Related]  

  • 7. The tenofovir pre-exposure prophylaxis trial in Thailand: researchers should show more openness in their engagement with the community.
    Chua A; Ford N; Wilson D; Cawthorne P
    PLoS Med; 2005 Oct; 2(10):e346. PubMed ID: 16231979
    [No Abstract]   [Full Text] [Related]  

  • 8. [3 years' data of tenofovir. Confirmed as a valuable building block].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():30-1. PubMed ID: 15373042
    [No Abstract]   [Full Text] [Related]  

  • 9. Encouraging results for tenofovir.
    AIDS Patient Care STDS; 2001 May; 15(5):289. PubMed ID: 11530770
    [No Abstract]   [Full Text] [Related]  

  • 10. Less than the sum of its parts: failure of a tenofovir-abacavir-Lamivudine triple-nucleoside regimen.
    Kuritzkes DR
    J Infect Dis; 2005 Dec; 192(11):1867-8. PubMed ID: 16267755
    [No Abstract]   [Full Text] [Related]  

  • 11. [Introduction. Tenofovir].
    Mallolas J
    Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():1. PubMed ID: 19195430
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to Joep M. A. Lange.
    Ditmore M
    PLoS Med; 2005 Oct; 2(10):e347. PubMed ID: 16231980
    [No Abstract]   [Full Text] [Related]  

  • 13. Many in VOICE trial didn't use provided prevention products.
    AIDS Policy Law; 2015 Mar; 30(4):3. PubMed ID: 26094276
    [No Abstract]   [Full Text] [Related]  

  • 14. Tenofovir disoproxil fumarate for the treatment of HIV infection.
    Pham PA; Gallant JE
    Expert Opin Drug Metab Toxicol; 2006 Jun; 2(3):459-69. PubMed ID: 16863446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Conclusions. Tenofovir].
    Mallolas J
    Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():62-4. PubMed ID: 19195439
    [No Abstract]   [Full Text] [Related]  

  • 16. Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence.
    Celum C; Baeten JM
    Curr Opin Infect Dis; 2012 Feb; 25(1):51-7. PubMed ID: 22156901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low rate of treatment failure on antiretroviral therapy with tenofovir, lamivudine and zidovudine.
    Mauss S; Milinkovic A; Hoffmann C; Holm S; Berger F; Martínez E; Kuhlmann B; Gatell J; Schmutz G
    AIDS; 2005 Jan; 19(1):101-2. PubMed ID: 15627042
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of Tenofovir gel as a PrEP on HIV infection: a mathematical model.
    Rahman SM; Vaidya NK; Zou X
    J Theor Biol; 2014 Apr; 347():151-9. PubMed ID: 24380779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease inhibitors and non-nucleoside reverse transcriptase inhibitors have a comparable effect on the CD4 cell change after switching to tenofovir-based regimens.
    van Leth F; Prins JM; Lange JM; Geerlings SE
    AIDS; 2005 Oct; 19(15):1722-3. PubMed ID: 16184059
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute renal failure, Fanconi syndrome and insipidus diabetes in a HIV-infected patient treated with Tenofovir].
    Harmouche H; Le Bras P; Bignani O; Delfraissy JF; Goujard C
    Rev Med Interne; 2005 Jun; 26(6):522-3. PubMed ID: 15936484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.